Sandoz Group AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1986-01-01
- Employees
- 20K
- Market Cap
- $19B
- Website
- http://www.sandoz.com
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Phase 1
Completed
- Conditions
- Psychosis
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 30
- Registration Number
- NCT00946491
To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 48
- Registration Number
- NCT00946465
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
Phase 1
Completed
- Conditions
- HypertensionAngina
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 28
- Registration Number
- NCT00946725
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Phase 2
Completed
- Conditions
- Asthma
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 105
- Registration Number
- NCT00927758
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸CompleWare, Iowa City, Iowa, United States
🇺🇸University of Wisconsin, Madison, Wisconsin, United States
To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 18
- Registration Number
- NCT00913887
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 36
- Registration Number
- NCT00913783
To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
Phase 1
Completed
- Conditions
- Allergy
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 36
- Registration Number
- NCT00913549
To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 46
- Registration Number
- NCT00913718
To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 36
- Registration Number
- NCT00913809
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions
Phase 1
Completed
- Conditions
- Depression
- Interventions
- Drug: Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting ConditionsDrug: Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed ConditionsDrug: Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 18
- Registration Number
- NCT00913952